Signaling by Environmental Polycyclic Aromatic Hydrocarbons in Human Lymphocytes

doi:10.1006/clim.2000.4934

Clinical Immunology

Volume 98, Issue 1, January 2001, Pages 2-10

https://doi.org/10.1006/clim.2000.4934 Get rights and content

Abstract

During the past decade there has been significant progress made in understanding how environmental agents, drugs, certain chemicals present in the diet, and occupational agents affect the immune system of animals and humans. Polycyclic aromatic hydrocarbons (PAHs) are an important class of environmentally prevalent xenobiotics that exert complex effects on the immune system. These agents, typified by benzo(a)pyrene (BaP), have been shown to alter antigen and mitogen receptor signaling pathways, leading to suppression of humoral and cell-mediated immunity, and at high exposure levels to activation of genes involved in apoptosis in lymphoid cells. Interestingly, at low exposure levels, PAHs may actually augment cell signaling pathways, resulting in immune enhancement or an adjuvant effect. While the biochemical targets and mechanisms responsible for immune modulation are still under investigation, several themes are evolving. PAHs, principally through their cytochrome-P450-derived metabolites, activate oxidative and electrophilic signaling pathways in lymphoid and nonlymphoid cells, including myeloid, epithelial, and other cells. Although PAHs affect signaling pathways in nonlymphoid cells leading to complex interactions between antigen-specific and nonspecific immune and inflammatory responses, this brief review focuses on the mechanisms of signaling by environmentally prevalent PAHs in human lymphocytes. Understanding the mechanisms by which xenobiotics alter adaptive and nonadaptive immune responses may shed light on the etiology of environmental and occupational immune diseases.

References (60)

M.I. Luster et al.
Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice
Fundam. Appl. Toxicol.
(1988)
M.I. Luster et al.
Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests
Fundam. Appl. Toxicol.
(1992)
M.I. Luster et al.
Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests
Fundam. Appl. Toxicol.
(1993)
M.I. Luster et al.
Use of animal studies in risk assessment for immunotoxicology
Toxicology
(1994)
B. Schoket et al.
Biomonitoring of human genotoxicity induced by complex occupational exposures
Mutat. Res.
(1999)
E.C. Ward et al.
Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance
Toxicol. Appl. Pharmacol.
(1984)
J.H. Dean et al.
Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance
Int. J. Immunopharmacol.
(1986)
M.J. Myers et al.
Inhibition of IL-2 responsiveness following exposure to benzo(a)pyrene is due to alterations in accessory cell function
Int. J. Immunopharmacol.
(1988)
E.C. Ward et al.
Persistent suppression of humoral and cell-mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a]anthracene
Int. J. Immunopharmacol.
(1986)
S.W. Burchiel et al.
Persistent suppression of humoral immunity produced by 7,12-dimethylbenz(a)anthracene (DMBA) in B6C3F1 mice: Correlation with changes in spleen cell surface markers detected by flow cytometry
Int. J. Immunopharmacol.
(1988)

S.W. Burchiel et al.

Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a]anthracene

Toxicol. Appl. Pharmacol.

(1990)

D.P. Davis et al.

Suppression of local gut-associated and splenic mitogen responsiveness of lymphoid cells following oral exposure of B6C3F1 mice to 7,12-dimethylbenz[a]anthracene

Fundam. Appl. Toxicol.

(1991)

L.M. Thurmond et al.

Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro

Toxicol. Appl. Pharmacol.

(1988)

S.P. Mudzinski

Effects of benzo[a]pyrene on concanavalin-A-stimulated human peripheral blood mononuclear cells in vitro: Inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle

Toxicol. Appl. Pharmacol.

(1993)

D.R. Davila et al.

Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by α-naphthoflavone

Toxicol. Appl. Pharmacol.

(1996)

S.C. Wood et al.

Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes

Fundam. Appl. Toxicol.

(1993)

K.K. Mann et al.

The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]-anthracene-induced pre-B lymphocyte apoptosis

Toxicol. Appl. Pharmacol.

(1999)

K. Yamaguchi et al.

Induction of preB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures

Toxicol. Appl. Pharmacol.

(1997)

S.W. Burchiel et al.

DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma

Fundam. Appl. Toxicol.

(1993)

V.M. Salas et al.

Apoptosis in Daudi human B cells in response to benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol

Toxicol. Appl. Pharmacol.

(1998)

G.S. Ladics et al.

Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone

Toxicol. Appl. Pharmacol.

(1991)

D.W. Nebert et al.

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

Biochem. Pharmacol.

(2000)

S.W. Burchiel et al.

Alterations in mitogen-induced calcium mobilization and intracellular free calcium produced by 7,12-dimethylbenz(a)anthracene (DMBA) in the Jurkat human T cell line

Int. J. Immunopharmacol.

(1991)

J.A. Krieger et al.

Persistence of calcium elevation in the HPB-ALL human T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons

Toxicol. Appl. Pharmacol.

(1994)

B.J. Mounho et al.

Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells

Toxicol. Appl. Pharmacol.

(1997)

B.J. Mounho et al.

Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: Possible associations with cytochrome P450 metabolism and increased protein tyrosine kinase phosphorylation

Toxicol. Appl. Pharmacol.

(1998)

S.W. Burchiel et al.

Uses and future applications of flow cytometry in immunotoxicity testing

Methods

(1999)

H. Bartsch

DNA adducts in human carcinogenesis: Etiological relevance and structure-activity relationship

Mutat. Res.

(1996)

J.W. Yuan et al.

Immunotoxic polycyclic aromatic hydrocarbons reduce intracellular glutathione levels in the A20.1 murine B cell lymphoma

Fundam. Appl. Toxicol.

(1994)

Cited by (185)

Effects of inhaled tier-2 diesel engine exhaust on immunotoxicity in a rat model: A hazard identification study. Part II. Immunotoxicology
2024, Toxicology Reports
Diesel exhaust (DE) is an air pollutant containing gaseous compounds and particulate matter. Diesel engines are common on gas extraction and oil sites, leading to complex DE exposure to a broad range of compounds through occupational settings. The US EPA concluded that short-term exposure to DE leads to allergic inflammatory disorders of the airways. To further evaluate the immunotoxicity of DE, the effects of whole-body inhalation of 0.2 and 1 mg/m³ DE (total carbon; 6 h/d for 4 days) were investigated 1-, 7-, and 27-days post exposure in Sprague-Dawley rats using an occupationally relevant exposure system. DE exposure of 1 mg/m³ increased total cellularity, number of CD4+ and CD8+ T-cells, and B-cells at 1 d post-exposure in the lung lymph nodes. At 7 d post-exposure to 1 mg/m³, cellularity and the number of CD4+ and CD8+ T-cells decreased in the LLNs. In the bronchoalveolar lavage, B-cell number and frequency increased at 1 d post-exposure, Natural Killer cell number and frequency decreased at 7 d post-exposure, and at 27 d post-exposure CD8+ T-cell and CD11b+ cell number and frequency decreased with 0.2 mg/m³ exposure. In the spleen, 0.2 mg/m³ increased CD4+ T-cell frequency at 1 and 7 d post-exposure and at 27 d post-exposure increased CD4+ and CD8+ T-cell number and CD8+ T-cell frequency. B-cells were the only immune cell subset altered in the three tissues (spleen, LLNs, and BALF), suggesting the induction of the adaptive immune response. The increase in lymphocytes in several different organ types also suggests an induction of a systemic inflammatory response occurring following DE exposure. These results show that DE exposure induced modifications of cellularity of phenotypic subsets that may impair immune function and contribute to airway inflammation induced by DE exposure in rats.
The immunotoxicity mechanism of hemocytes in Chlamys farreri incubated with noradrenaline and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide alone or in combination
2024, Fish and Shellfish Immunology
Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE) is the active intermediate metabolite of benzo[a]pyrene (B[a]P) and is considered the ultimate immunotoxicant. The neuroendocrine immunoregulatory network of bivalves is affected under pollutant stress. Besides, bivalves are frequently affected by pollutants in marine environments, yet the combined effects of neuroendocrine factors and detoxification metabolites on bivalves under pollutant stress and the signal pathways that mediate this immunoregulation are not well understood. Therefore, we incubated the hemocytes of Chlamys farreri with the neuroendocrine factor noradrenaline (NA) and the B[a]P detoxification metabolite BPDE, alone or in combination, to examine the immunotoxic effects of NA and BPDE on the hemocytes in C. farreri. Furthermore, the effects of NA and BPDE on the hemocyte signal transduction pathway were investigated by assessing potential downstream targets. The results revealed that NA and BPDE, alone or in combination, resulted in a significant decrease in phagocytic activity, bacteriolytic activity and the total hemocyte count. In addition, the immunotoxicity induced by BPDE was further exacerbated by co-treatment with NA, and the two showed synergistic effects. Analysis of signaling pathway factors showed that NA activated G proteins by binding to α-AR, which transmitted information to the Ca²⁺-NF-κB signaling pathway to regulate the expression of phagocytosis-associated proteins and regulated cytokinesis through the cAMP signaling pathway. BPDE could activate PTK and affect phagocytosis and cytotoxicity proteins through Ca²⁺-NF-κB signal pathway, also affect the regulation of phagocytosis and cytotoxicity by inhibiting the AC-cAMP-PKA pathway to down-regulate the expression of NF-κB and CREB. In addition, BPDE and NA may affect the immunity of hemocytes by down-regulating phagocytosis-related proteins through inhibition of the lectin pathway, while regulating the expression of cytotoxicity-related proteins through the C-type lectin. In summary, immune parameters were suppressed through Ca²⁺ and cAMP dependent pathways exposed to BPDE and the immunosuppressive effects were enhanced by the neuroendocrine factor NA.
Using machine learning methods to analyze the association between urinary polycyclic aromatic hydrocarbons and chronic bowel disorders in American adults
2024, Chemosphere
The etiology of chronic bowel disorders is multifaceted, with environmental exposure to harmful substances potentially playing a significant role in their pathogenesis. However, research on the correlation between polycyclic aromatic hydrocarbons (PAHs) and chronic bowel disorders remains limited. Using data from the National Health and Nutrition Examination Survey (NHANES) conducted in 2009–2010, we investigated the relationship between 9 PAHs and chronic diarrhea and constipation in U.S. adults. We employed unsupervised methods such as clustering and Principal Component Analysis (PCA) to identify participants with similar exposure patterns. Additionally, we used supervised learning techniques, namely weighted quantile sum (WQS) and Bayesian kernel machine (BKMR) regressions, to assess the association between PAHs and the occurrence of chronic diarrhea and chronic constipation. PCA identified three principal components in the unsupervised analysis, explaining 86.5% of the total PAH variability. The first component displayed a mild association with chronic diarrhea, but no correlation with chronic constipation. Participants were divided into three clusters via K-means clustering, based on PAH concentrations. Clusters with higher PAH exposure demonstrated an increased odds ratio for chronic diarrhea, but no meaningful connection with chronic constipation. In the supervised analysis, the WQS regression underscored a positive relationship between the PAH mixture and chronic diarrhea, with three PAHs significantly impacting the mixture effect. The mixture index showed no correlation with chronic constipation. BKMR analysis illustrated a positive trend in the impact of four specific PAHs on chronic diarrhea, given other metabolites were fixed at their 50th percentiles. Our results suggest a clear association between higher PAH exposure and an increased risk of chronic diarrhea, but not chronic constipation. It also underscores the potential role of specific PAHs in contributing to the risk of chronic diarrhea.
A critical insight into occurrence and fate of polycyclic aromatic hydrocarbons and their green remediation approaches
2023, Chemosphere
Over the last century, the tremendous growth in industrial activities particularly in the sectors of pharmaceuticals, petrochemicals and the reckless application of fertilizers and insecticides has raised the contamination of polyaromatic hydrocarbons (PAHs) tremendously. For more than a decade, the main focus of environmental experts is to come up with management approaches for the clean-up of sites polluted with PAHs. These are ubiquitous in nature i.e., widely distributed in ecosystem ranging from soil, air and marine water. Most of the PAHs possess immunotoxicity, carcinogenicity and genotoxicity. Being highly soluble in lipids, they are readily absorbed into the mammalian gastro intestinal tract. They are widely distributed with marked tendency of getting localized into body fat in varied tissues. Several remediation technologies have been tested for the removal of these environmental contaminants, particularly bioremediation has turned out to be a hope as the safest and cost-effective option. Therefore, this review first discusses various sources of PAHs, their effect on human health and interactions of PAHs with soils and sediments. In this review, a holistic insight of current scenario of existing remediation technologies and how they can be improvised along with the hindrances in the path of these technologies are properly addressed.
Polyaromatic hydrocarbons (PAHs) in the water environment: A review on toxicity, microbial biodegradation, systematic biological advancements, and environmental fate
2023, Environmental Research
Polycyclic aromatic hydrocarbons (PAHs) are considered a major class of organic contaminants or pollutants, which are poisonous, mutagenic, genotoxic, and/or carcinogenic. Due to their ubiquitous occurrence and recalcitrance, PAHs-related pollution possesses significant public health and environmental concerns. Increasing the understanding of PAHs' negative impacts on ecosystems and human health has encouraged more researchers to focus on eliminating these pollutants from the environment. Nutrients available in the aqueous phase, the amount and type of microbes in the culture, and the PAHs' nature and molecular characteristics are the common factors influencing the microbial breakdown of PAHs. In recent decades, microbial community analyses, biochemical pathways, enzyme systems, gene organization, and genetic regulation related to PAH degradation have been intensively researched. Although xenobiotic-degrading microbes have a lot of potential for restoring the damaged ecosystems in a cost-effective and efficient manner, their role and strength to eliminate the refractory PAH compounds using innovative technologies are still to be explored. Recent analytical biochemistry and genetically engineered technologies have aided in improving the effectiveness of PAHs' breakdown by microorganisms, creating and developing advanced bioremediation techniques. Optimizing the key characteristics like the adsorption, bioavailability, and mass transfer of PAH boosts the microorganisms' bioremediation performance, especially in the natural aquatic water bodies. This review's primary goal is to provide an understanding of recent information about how PAHs are degraded and/or transformed in the aquatic environment by halophilic archaea, bacteria, algae, and fungi. Furthermore, the removal mechanisms of PAH in the marine/aquatic environment are discussed in terms of the recent systemic advancements in microbial degradation methodologies. The review outputs would assist in facilitating the development of new insights into PAH bioremediation.
The role of NUPR1 in response to stress and cancer development
2022, Toxicology and Applied Pharmacology
Stress contributes to the development of many human diseases, including cancer. Based on the source of stress, it can be divided into external stress, such as environmental carcinogens, chemicals, and radiation, and internal stress, like endoplasmic reticulum (ER) stress, hypoxia, and oxidative stress. Nuclear Protein 1 (NUPR1, p8 or Com-1) is a small, highly basic transcriptional regulator that participates in regulating a variety of cellular processes including DNA repair, ER stress, oxidative stress response, cell cycle, autophagy, apoptosis, ferroptosis and chromatin remodeling. A large number of studies have reported that NUPR1 expression can be stimulated rapidly in response to various stresses. Thus, NUPR1 is also known as a stress-response gene. Since the role of NUPR1 in breast cancer was identified in 1999, an increasing number of studies sought to reveal its function in cancer. High expression of NUPR1 has been identified in oral squamous cell carcinoma, breast cancer, lung cancer, multiple myeloma, liver cancer and renal cancer. In this review, we summarize current studies of NUPR1 in response to multiple external stressors and internal stressors, and its role in mediating stressors to cause different cell signaling responses. In addition, this review discusses the function of NUPR1 in carcinogenesis, tumorigenesis, metastasis, and cancer therapy. Thus, this review gives a comprehensive insight into the role of NUPR1 in mediating signals from stress to different cell responses, and this process plays a role in the development of cancer.

View all citing articles on Scopus

^☆: The work reported by S.W.B. was supported in part by NIH Grant RO1 ES-05495 and by NIEHS Developmental Center Grant P20 ES-09871.

²: To whom correspondence and reprint requests should be addressed at The University of New Mexico College of Pharmacy Toxicology Program, 2502 Marble NE, Albuquerque, NM 87131-5691. Fax: (505) 272-6749. E-mail: [email protected].

View full text

Regular ArticleSignaling by Environmental Polycyclic Aromatic Hydrocarbons in Human Lymphocytes☆

Abstract

Fundam. Appl. Toxicol.

Fundam. Appl. Toxicol.

Fundam. Appl. Toxicol.

Toxicology

Mutat. Res.

Toxicol. Appl. Pharmacol.

Int. J. Immunopharmacol.

Int. J. Immunopharmacol.

Int. J. Immunopharmacol.

Int. J. Immunopharmacol.

Toxicol. Appl. Pharmacol.

Fundam. Appl. Toxicol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Fundam. Appl. Toxicol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Fundam. Appl. Toxicol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Biochem. Pharmacol.

Int. J. Immunopharmacol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Toxicol. Appl. Pharmacol.

Methods

Mutat. Res.

Fundam. Appl. Toxicol.

Regular Article
Signaling by Environmental Polycyclic Aromatic Hydrocarbons in Human Lymphocytes☆